브리스톨 마이어스 스퀴브(Bristol-Myers Squibb) 회사
US ˙ NYSE ˙ US1101221083

SecurityBMY / Bristol-Myers Squibb Company
InstitutionAGF Investments LLC
Latest Disclosed Ownership23,897 shares
Latest Disclosed Value $ 1,699,000
AGF Investments LLC reports 94.90% increase in ownership of BMY / Bristol-Myers Squibb Company

On November 10, 2022 - AGF Investments LLC filed a 13F-HR form disclosing ownership of 23,897 shares of Bristol-Myers Squibb Company (US:BMY) valued at $1,698,838 USD as of September 30, 2022. The entity filed a previous 13F-HR on August 12, 2022 disclosing 12,261 shares of Bristol-Myers Squibb Company. This represents a change in shares of 94.90% during the quarter. The current value of the position is $1,368,581 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2022-11-10 2022-09-30 13F Bristol-Myers Squibb COM 110122108 23,897 11,636 94.90 1,699 79.98 0.1558
2022-08-12 2022-06-30 13F Bristol-Myers Squibb COM 110122108 12,261 -459 -3.61 944 1.61 0.0884
2022-05-10 2022-03-31 13F Bristol-Myers Squibb COM 110122108 12,720 -4,003 -23.94 929 -10.93 0.0776
2022-02-01 2021-12-31 13F Bristol-Myers Squibb COM 110122108 16,723 13,899 492.17 1,043 524.55 0.0878
2021-11-10 2021-09-30 13F Bristol-Myers Squibb COM 110122108 2,824 -171 -5.71 167 -16.50 0.0165
2021-08-12 2021-06-30 13F Bristol-Myers Squibb COM 110122108 2,995 1 0.03 200 5.82 0.0207
2021-05-14 2021-03-31 13F Bristol-Myers Squibb COM 110122108 2,994 -2,004 -40.10 189 -39.03 0.0226
2021-02-08 2020-12-31 13F Bristol-Myers Squibb COM 110122108 4,998 -222 -4.25 310 -1.59 0.0368
2020-11-12 2020-09-30 13F Bristol-Myers Squibb COM 110122108 5,220 -25,324 -82.91 315 -82.46 0.0352
2020-08-11 2020-06-30 13F Bristol-Myers Squibb COM 110122108 30,544 -13,564 -30.75 1,796 -26.96 0.1825
2020-05-08 2020-03-31 13F Bristol-Myers Squibb COM 110122108 44,108 -4,400 -9.07 2,459 -21.03 0.3185
2020-02-12 2019-12-31 13F Bristol-Myers Squibb COM 110122108 48,508 37,830 354.28 3,114 475.60 0.5789
2019-11-12 2019-09-30 13F Bristol-Myers Squibb COM 110122108 10,678 3,095 40.81 541 57.27 0.1271
2019-07-30 2019-06-30 13F Bristol-Myers Squibb COM 110122108 7,583 3,915 106.73 344 96.57 0.0718
2019-05-13 2019-03-31 13F Bristol-Myers Squibb COM 110122108 3,668 -72,978 -95.21 175 -95.61 0.0392
2019-02-08 2018-12-31 13F Bristol-Myers Squibb COM 110122108 76,646 3,966 5.46 3,984 -11.70 0.5500
2018-11-09 2018-09-30 13F/A-1 Bristol-Myers Squibb Common Stock 110122108 72,680 12,569 20.91 4,512 35.62 0.5725
2018-08-13 2018-06-30 13F Bristol-Myers Squibb Common Stock 110122108 60,111 -5,214 -7.98 3,327 -19.38 0.3808
2018-05-04 2018-03-31 13F Bristol-Myers Squibb Common Stock 110122108 65,325 -11,455 -14.92 4,127 -12.28 0.6955
2018-02-07 2017-12-31 13F Bristol-Myers Squibb Common Stock 110122108 76,780 14,520 23.32 4,705 18.57 0.8124
2017-11-09 2017-09-30 13F Bristol-Myers Squibb Common Stock 110122108 62,260 13,127 26.72 3,968 44.92 0.8797
2017-08-09 2017-06-30 13F Bristol-Myers Squibb Common Stock 110122108 49,133 2,958 6.41 2,738 9.04 0.6271
2017-05-08 2017-03-31 13F Bristol-Myers Squibb Common Stock 110122108 46,175 2,825 6.52 2,511 -0.91 0.6317
2017-02-01 2016-12-31 13F BRISTOL-MYERS SQUIBB Common Stock 110122108 43,350 43,350 2,534 0.6698
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.